A feasibility study of recombinant adeno-associated virus as a vector for transferring a target gene to retina

被引:0
|
作者
Wang, Jian-Ming [1 ]
Fan, Ya-Zhi [1 ]
Hui, Na [1 ]
Xiong, Lei [1 ]
Feng, Hai-Xiao [1 ]
Sun, Nai-Xue [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 2, Coll Med, Dept Ophthalmol, Xian 710004, Shaanxi, Peoples R China
关键词
recombinant adeno-associated virus; green fluorescent protein gene; gene transfer; retina; TRANSGENE EXPRESSION; DELIVERY;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
AIM: To study the feasibility of recombinant adeno-associated virus (rAAV) as a vector to transfer the green fluorescent protein (GP) gene as a target gene into rabbit retina. METHODS: Intravitreal injection of rAAV-gfp was performed in either eye for each rabbit with the other eye taken as control. At the 3rd, 7th, and 14th day after injection, the eyeballs were removed, and the retinas were flat-mounted on glass slides to inspect the retinal fluorescence, respectively. RESULTS: After intravitreal injection of rAAV-gfp, the presence of fluorescent spots in the cytoplasm of retinal cells indicated that GFP gene was efficiently transferred and expressed in the rabbit retina. CONCLUSION: Recombinant adeno-assodated virus is a reliable and simple vector for transferring target gene, e.g., GFP gene, to the retina.
引用
收藏
页码:143 / 145
页数:3
相关论文
共 50 条
  • [31] Recombinant adeno-associated virus for muscle directed gene therapy
    Fisher, KJ
    Jooss, K
    Alston, J
    Yang, YP
    Haecker, SE
    High, K
    Pathak, R
    Raper, SE
    Wilson, JM
    NATURE MEDICINE, 1997, 3 (03) : 306 - 312
  • [32] Development of recombinant adeno-associated virus (rAAV) as a genetic vaccine vector
    Logan, GJ
    Zheng, ML
    Coppel, RL
    Rowe, PB
    Wang, LN
    Alexander, IE
    JOURNAL OF GENE MEDICINE, 2005, 7 (08): : 1121 - 1121
  • [33] The use of recombinant adeno-associated virus for skeletal gene therapy
    Dai, Juan
    Rabie, A. Bakr M.
    ORTHODONTICS & CRANIOFACIAL RESEARCH, 2007, 10 (01) : 1 - 14
  • [34] Production of recombinant adeno-associated virus
    Gao, GP
    Wilson, JM
    Wivel, NA
    ADVANCES IN VIRUS RESEARCH, VOL 55, 2000, 55 : 529 - 543
  • [35] Biological Activation of Biomaterials by Recombinant Adeno-Associated Virus Vector.
    Ito, H.
    Nasu, T.
    Tsutsumi, R.
    Kitaori, T.
    Schwarz, E. M.
    Nakamura, T.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S275 - S275
  • [36] Recombinant adeno-associated virus for muscle directed gene therapy
    Krishna J. Fisher
    Karin Jooss
    James Alston
    Yiping Yang
    Sarah Ehlen Haecker
    Katherine High
    Ravindra Pathak
    Steven E. Raper
    James M. Wilson
    Nature Medicine, 1997, 3 : 306 - 312
  • [37] Molecular design for recombinant adeno-associated virus (rAAV) vector production
    Juan Jose Aponte-Ubillus
    Daniel Barajas
    Joseph Peltier
    Cameron Bardliving
    Parviz Shamlou
    Daniel Gold
    Applied Microbiology and Biotechnology, 2018, 102 : 1045 - 1054
  • [38] Complexation of recombinant adeno-associated virus with polyelectrolytes for gene delivery
    Hsu, P.
    Yang, Y. W.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1403 - 1404
  • [39] Production requirements for recombinant adeno-associated virus gene therapies
    Kotin, Robert M.
    JOURNAL OF GENE MEDICINE, 2007, 9 (06): : 524 - 524
  • [40] Human CBS (cystathionine β-synthase) gene transfer mediated by recombinant adeno-associated virus vector
    Oh, HJ
    Park, ES
    Kruger, W
    Jung, SC
    Lee, JS
    MOLECULAR THERAPY, 2004, 9 : S69 - S70